STE - Steris Plc Stock Analysis
Steris Plc (STE) is a publicly traded company listed on the NYSE. It operates in the Medical Devices industry, part of the broader Healthcare sector. The company has a market capitalization of 25.36B, generates annual revenue of 5.70B, and reports net income of 694.29M. As of the latest data, the stock is trading at 258.41 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. The dividend yield (0.95%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.92), indicating current market sentiment. Institutional ownership is reported at 95.93%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 16.02%, trading within a 52-week range of 200.98 - 268.30.
STE - Steris Plc
258.41
Analyst Consensus
Hold 3.92
STE – Analyst Rating Summary
- Strong Buy: 3
- Buy: 6
- Hold: 4
- Sell: 0
- Strong Sell: 0
- Total Analysts: 13
| Index: | S&P 500 | P/E: | 36.78 | EPS (ttm): | 7.03 | Insider Own: | 0.33% | Shs Outstand: | 98.10M | Perf Week: | -2.03% |
| Market Cap: | 25.36B | Forward P/E: | 23.21 | EPS next Y: | 11.13 | Insider Trans: | -16.99% | Shs Float: | 97.82M | Perf Month: | 7.54% |
| Income(ttm): | 694.29M | PEG: | 3.84 | EPS next Q: | 2.53 | Inst Own: | 95.93% | Short Float: | 0.98% | Perf Quarter: | 5.66% |
| Revenue(ttm): | 5.70B | P/S: | 4.45 | EPS this Y: | 9.38% | Inst Trans: | 1.34% | Short Ratio: | 1.58 | Perf Half Y: | 2.71% |
| Book/sh: | 71.45 | P/B: | 3.62 | EPS next Y: | 9.11% | ROA: | 6.68% | Short Interest: | 0.96M | Perf Year: | 16.02% |
| Cash/sh: | 3.25 | P/C: | 79.46 | EPS next 5Y: | 9.57% | ROE: | 10.14% | 52W Range: | 200.98 - 268.30 | Perf YTD: | 25.71% |
| Dividend Est.: | 2.46 (0.95%) | P/FCF: | 26.45 | EPS past 3/5Y: | 36.77% 5.92% | ROIC: | 7.69% | 52W High: | 268.30 -3.69% | Beta: | 1.00 |
| Dividend TTM: | 2.34 (0.91%) | Quick Ratio: | 1.63 | Sales past 3/5Y: | 5.99% 12.49% | Gross Margin: | 44.52% | 52W Low: | 200.98 28.57% | Perf 5Y: | 35.97% |
| Dividend Ex-Date: | Nov 18, 2025 | Current Ratio: | 2.37 | EPS Y/Y TTM: | 60.30% | Oper. Margin: | 18.60% | RSI (14): | 61.66 | Volatility: | 2.07% 2.17% |
| Employees: | 17787 | Debt/Eq: | 0.29 | Sales Y/Y TTM: | 5.15% | Profit Margin: | 12.18% | Recom: | 2.00 | Target Price: | 288.86 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.29 | EPS Q/Q: | 28.43% | Payout: | 35.14% | Rel Volume: | 0.83 | Prev Close: | 260.44 |
| Sales Surprise: | 4.79% | EPS Surprise: | 5.05% | Sales Q/Q: | 9.89% | Earnings: | Nov 05 AMC | Avg Volume: | 607.60K | Price: | 258.41 |
| SMA20: | 4.12% | SMA50: | 5.06% | SMA200: | 9.95% | Undervalued: 11.78% | Volume: | 504,367 | Change: | -0.78% | |
Graham Classic formula value: 174.48
(P/E=8 * 1g) Min value: 110.91
(current P/E * 2g) Max value: 353.0
Average value: 212.8
About Steris Plc
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.